The Personalised Medicine Consortium (PMC) is pleased to announce the launch of the 2017 call for proposals of its PMC Pump Prime Fund.
The fund is an initiative launched in 2014 by the founding members of the PMC in an effort to solve unmet clinical needs, foster interactions between Luxembourg-based research institutes and hospitals, and help researchers over the first hurdle of getting an innovative project off the ground before seeking external funding.
The institutes behind the PMC, the LIH (Luxembourg Institute of Health), the LCSB (Luxembourg Centre for Systems Biomedicine) and IBBL (Integrated BioBank of Luxembourg) are not only the initiators of the PMC Pump Prime Fund; they also provide the funding for up to three successful projects per call edition.
This year marks the third call for proposals of the PMC Pump Prime Fund. The call is open to Luxembourg-based researchers in the field of translational biomedical research and must include investigators from at least two of the PMC-funding institutes: LIH, IBBL and LCSB.
For full details about the call, the conditions of eligibility and the application process, please visit: https://www.ibbl.lu/research/personalised-medicine-consortium/
Call deadline:
The call opened on 1st September 2016. All application forms should be completed and submitted to pmc@ibbl.lu by 15th October 2016.